CHB patients with hepatic steatosis were more likely to have higher levels of TC, TG, GLU, UA, and BMI; be of themale sex; be aged >40 years; have hyperuricaemia and a BMI > 23 kg/m2; and have significantly lower ALT and AST levels than those without hepatic steatosis. The gene discussed is GPT; the disease is fatty liver disease.